DecisionDx-SCC is validated to predict metastatic risk for individual SCC patients with one or more risk factors. It provides unique information for squamous cell skin cancer. Incorporation of risk factors with DecisionDx-SCC test results provides superior risk assessment to either approach alone. DecisionDx-SCC can complement current cancer risk factor staging systems for patients with high-risk SCC.
Ten published studies
Squamous cell skin cancer patients with one or more risk factors
Medical centers across the United States
Metastasis-free survival validated predictor
DecisionDx-SCC May Be Right for You
Talk to your healthcare provider and healthcare team to learn more about how DecisionDx-SCC test results can be used to help better assess the risk of your cancer spreading and enable you to personalize your treatment and ongoing management.
Learn How Genomic Testing Can Help Determine Your Personalized Risk